SCHEMBL10143201

SCHEMBL10143201

Cc1cc(SCC=C(c2ccc(Br)cc2)c2ccc(-c3ccccc3)cc2)ccc1OCC(=O)O

nearest known ligand 0.88

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 19/20 0.88
PPARA Q07869 2/20 0.53
PPARG P37231 2/20 0.49
PTGDR2 Q9Y5Y4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10143210 1.00 PPARD (0.88) PPARDPPARAPPARGPTGDR2
SCHEMBL659025 1.00 PPARD (0.88) PPARDPPARAPPARGPTGDR2
SCHEMBL3269098 0.95 PPARD (0.94) PPARDPPARAPTGDR2
SCHEMBL13234246 0.95 PPARD (0.94) PPARDPPARAPTGDR2
SCHEMBL3269095 0.95 PPARD (0.94) PPARDPPARAPTGDR2
SCHEMBL5959504 0.95 PPARD (0.78) PPARDPPARAPPARG
SCHEMBL5959547 0.95 PPARD (0.78) PPARDPPARAPPARG
SCHEMBL12159944 0.94 PPARD (0.77) PPARDPPARAPPARG
SCHEMBL657073 0.94 PPARD (1.00) PPARDPPARAPTGDR2
SCHEMBL657912 0.92 PPARD (0.85) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046350-A1 NOVEL COMPOUNDS, THEIR PREPARATION AND USE HIGH POINT PHARMACEUTICALS, LLC (US) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046350-A1 NOVEL COMPOUNDS, THEIR PREPARATION AND USE PPARG, PPARD, PPARA PPARD 2/4885PPARA 3/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.